• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

台湾地区人类细小病毒B19的血清流行病学研究。

Seroepidemiology of human parvovirus B19 in Taiwan.

作者信息

Lin K H, You S L, Chen C J, Wang C F, Yang C S, Yamazaki S

机构信息

Department of Clinical Laboratory, Kaohsiung Medical College, Taiwan, Republic of China.

出版信息

J Med Virol. 1999 Feb;57(2):169-73.

PMID:9892403
Abstract

In order to determine the prevalence and risk factors of human parvovirus B19 (B19) infection in Taiwan, a seroepidemiological study was carried out in 19 townships. Serum samples were collected from 862 healthy residents, who were selected by stratified random sampling from various study areas. They were chosen from four different ethnic groups including aborigines, Fukien Taiwanese, Hakka Taiwanese, and mainland Chinese. Serum samples were screened for B19 IgG antibody by indirect antibody capture enzyme-linked immunosorbent assay (ELISA) and B19 IgM by IgM antibody capture (MAC)-ELISA, respectively. The overall prevalence of anti-B19 IgG and anti-B19 IgM was 32.8% and 0.35%, respectively. The anti-B19 seropositive rate in females was significantly higher than that of males (36.4% vs. 29.4%, P < .001). The age-sex-adjusted seropositive rate in urban townships (39.9%) was higher than that in aboriginal townships (30.5%, P < .001). The seropositive rate increased significantly with age showing a dose-response relationship (P=0.0001 based on a trend test). Blood transfusion was found to be associated with an increased seropositive rate showing a multivariate-adjusted odds ratios of 1.6.

摘要

为了确定台湾地区人类细小病毒B19(B19)感染的流行率及危险因素,在19个乡镇开展了一项血清流行病学研究。从862名健康居民中采集血清样本,这些居民是从各个研究区域通过分层随机抽样选取的。他们来自四个不同的族群,包括原住民、台湾闽南人、台湾客家人和中国大陆人。分别采用间接抗体捕获酶联免疫吸附测定(ELISA)检测血清样本中的B19 IgG抗体,采用IgM抗体捕获(MAC)-ELISA检测B19 IgM。抗B19 IgG和抗B19 IgM的总体流行率分别为32.8%和0.35%。女性的抗B19血清阳性率显著高于男性(36.4%对29.4%,P <.001)。城市乡镇经年龄-性别调整后的血清阳性率(39.9%)高于原住民乡镇(30.5%,P <.001)。血清阳性率随年龄显著增加,呈现剂量反应关系(基于趋势检验,P = 0.0001)。发现输血与血清阳性率增加相关,多变量调整后的优势比为1.6。

相似文献

1
Seroepidemiology of human parvovirus B19 in Taiwan.台湾地区人类细小病毒B19的血清流行病学研究。
J Med Virol. 1999 Feb;57(2):169-73.
2
[Prevalence of anti-human parvovirus B19 IgG antibody among blood donors in Jilin province].[吉林省献血者中抗人细小病毒B19 IgG抗体的流行率]
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2006 Jun;20(2):60-2.
3
Parvovirus B19 infection in Taiwanese patients with hematological disorders.台湾血液系统疾病患者中的B19微小病毒感染
J Med Virol. 2003 Dec;71(4):605-9. doi: 10.1002/jmv.10517.
4
Seroepidemiology of Hantaan virus infection in Taiwan.台湾地区汉坦病毒感染的血清流行病学研究
J Med Virol. 1996 Dec;50(4):309-13. doi: 10.1002/(SICI)1096-9071(199612)50:4<309::AID-JMV5>3.0.CO;2-C.
5
[Seroprevalence of parvovirus B19 in patients with chronic idiopathic thrombocytopenic purpura].[慢性特发性血小板减少性紫癜患者中B19微小病毒的血清流行率]
Mikrobiyol Bul. 2007 Oct;41(4):597-602.
6
[Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].[突尼斯一家医院中细小病毒B19感染与慢性关节表现的研究]
Arch Inst Pasteur Tunis. 2003;80(1-4):9-15.
7
[Comparative study of indirect immunofluorescence (IIF) and ELISA techniques in the detection of parvovirus B19].间接免疫荧光法(IIF)与酶联免疫吸附测定(ELISA)技术检测B19细小病毒的对比研究
Invest Clin. 2000 Mar;41(1):19-27.
8
Parvovirus B19 may have a role in the pathogenesis of juvenile idiopathic arthritis.细小病毒B19可能在幼年特发性关节炎的发病机制中起作用。
J Rheumatol. 2007 Jun;34(6):1336-40. Epub 2007 May 1.
9
Seroepidemiology of human T-cell lymphotropic virus type I infection in Taiwan.
Cancer Res. 1988 Sep 1;48(17):5042-4.
10
Low seroprevalence of parvovirus B19 in Taiwanese children and young adults.台湾地区儿童和青年人群中细小病毒 B19 的血清流行率较低。
Pediatr Neonatol. 2010 Oct;51(5):265-8. doi: 10.1016/S1875-9572(10)60051-4.

引用本文的文献

1
Increased parvovirus B19 seropositivity in healthy blood donors in India.印度健康献血者中细小病毒 B19 血清阳性率增高。
Sci Rep. 2024 Sep 3;14(1):20497. doi: 10.1038/s41598-024-68095-2.
2
Effect of the Functional VP1 Unique Region of Human Parvovirus B19 in Causing Skin Fibrosis of Systemic Sclerosis.人细小病毒 B19 功能性 VP1 独特区导致系统性硬皮病皮肤纤维化的作用。
Int J Mol Sci. 2023 Oct 18;24(20):15294. doi: 10.3390/ijms242015294.
3
Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar.
在卡塔尔居住的不同国籍献血者中细小病毒(B19V)的流行情况及系统进化分析。
Viruses. 2021 Mar 24;13(4):540. doi: 10.3390/v13040540.
4
Seroprevalence of antibodies to primate erythroparvovirus 1 (B19V) in Australia.澳大利亚灵长类细小病毒 1(B19V)抗体的血清流行率。
BMC Infect Dis. 2018 Dec 7;18(1):631. doi: 10.1186/s12879-018-3525-7.
5
Seroepidemiology of parvovirus B19 among different age groups & pregnant women in India.印度不同年龄组及孕妇中B19细小病毒的血清流行病学研究
Indian J Med Res. 2017 Jul;146(1):138-140. doi: 10.4103/ijmr.IJMR_1847_15.
6
Human Parvoviruses.人类细小病毒
Clin Microbiol Rev. 2017 Jan;30(1):43-113. doi: 10.1128/CMR.00040-16.
7
Standardization of B19 IgG ELISA to study the seroepidemiology of parvovirus B19 in North Indian voluntary blood donors.B19 IgG酶联免疫吸附测定标准化以研究印度北部无偿献血者中细小病毒B19的血清流行病学。
Asian J Transfus Sci. 2010 Jul;4(2):86-90. doi: 10.4103/0973-6247.67022.
8
Increased risk of parvovirus B19 infection in young adult cancer patients receiving multiple courses of chemotherapy.接受多疗程化疗的年轻成年癌症患者感染细小病毒B19的风险增加。
J Clin Microbiol. 2002 Nov;40(11):3909-12. doi: 10.1128/JCM.40.11.3909-3912.2002.